Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 258

Sort by

Sort Order Select

Journal Articles

How I treat obese patients with oral anticoagulants

Tzu-Fei Wang, Marc Carrier

Blood (2020) 135 (12): 904–911.

https://doi.org/10.1182/blood.2019003528

Published: 2020

Journal Articles

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

Teresa Cafaro, MD, Vicky Tagalakis, MD FRCPC, Maral Koolian, MD FRCPC, Simard Camille, MD

Blood (2019) 134 (Supplement_1): 2445.

https://doi.org/10.1182/blood-2019-128849

Published: 2019

Journal Articles

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Ashley Pinchinat, MD, Neida Otero, Harshini Mahanti, BS, MSCR, Erin Morris, RN, BSN, Adele Brudnicki, MD, Deborah Friedman, MD, Simon Li, MD, Oya Levendoglu-Tugal, MD, Mitchell S Cairo, MD

Blood (2019) 134 (Supplement_1): 2443.

https://doi.org/10.1182/blood-2019-130468

Published: 2019

Journal Articles

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

Steven Deitelzweig, MD, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Lisa Rosenblatt, MD MPH, Cristina Russ, MD PhD, Kenneth Tuell, RPh, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA, Jennifer D Guo, PhD

Blood (2019) 134 (Supplement_1): 2157.

https://doi.org/10.1182/blood-2019-125845

Published: 2019

Journal Articles

In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants

Christopher Cipkar, MD BSc, Sujitha Srinathan, Philip Chiang, BMSc, Lana A Castellucci, MD FRCPC, MSc

Blood (2019) 134 (Supplement_1): 3668.

https://doi.org/10.1182/blood-2019-131769

Published: 2019

Journal Articles

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Yimin Pearl Wang, BSc, Rohan Kehar, MDMSc,FRCPC, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 3672.

https://doi.org/10.1182/blood-2019-123870

Published: 2019

Journal Articles

Risk of Postoperative Bleeding Following Dental Extractions in Patients on Antithrombotic Treatment

Mohammed Abdullah Alsheef, MD, Jenny Gray, Abdul Rehman Z. Zaidi, MBBS, AbdulSalam S AlJabab, MD

Blood (2019) 134 (Supplement_1): 4960.

https://doi.org/10.1182/blood-2019-128125

Published: 2019

Journal Articles

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Muhammad Saad Farooq, MBBS, Aakash Putta, MD MBBS, Sheeba Ba Aqeel, VV Pavan Kedar Mukthinuthalapati, Ankit Mangla, MBBS, MD, Paul Rubinstein, MD

Blood (2019) 134 (Supplement_1): 4963.

https://doi.org/10.1182/blood-2019-129607

Published: 2019

Journal Articles

Prothrombin Complex Concentrate in the Management of Major Bleeding Induced By Oral Anticoagulant Therapy: Experience of a Tertiary Care Center

Mohammed Abdullah Alsheef, MD, Abdul Rehman Z. Zaidi, MBBS, Ghaydaa Juma Kullab, MD

Blood (2019) 134 (Supplement_1): 4967.

https://doi.org/10.1182/blood-2019-126740

Published: 2019

Journal Articles

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Shveta Gupta, MBBS, Ayesha Zia, MD, Ravindra Sarode, MD

Blood (2019) 134 (Supplement_1): 4976.

https://doi.org/10.1182/blood-2019-129118

Published: 2019

Journal Articles

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

Haoxu Ouyang, MD PhD, Ratesh Khillan, Nyein Htway Yu, MBBS, MD, Mohan Preet, MD

Blood (2019) 134 (Supplement_1): 4927.

https://doi.org/10.1182/blood-2019-132283

Published: 2019

Journal Articles

Assessment of Utilization of Outpatient Based Treatment for Low Risk Patients with Pulmonary Embolism in Two Community Teaching Hospitals

Kavita Agrawal, Nirav Agrawal, Harsha Adnani, Anjali Kakwani

Blood (2019) 134 (Supplement_1): 5779.

https://doi.org/10.1182/blood-2019-131294

Published: 2019

Journal Articles

Heavy Menstrual Bleeding Under-Recognized in Menstruating Women Treated with Oral Anticoagulants

Vivia Chi, MDcal Student, Maureen Baldwin, MD, Bethany T. Samuelson Bannow, MD

Blood (2019) 134 (Supplement_1): 60.

https://doi.org/10.1182/blood-2019-131026

Published: 2019

Journal Articles

Perception of Dentists and Dental Hygienists in Saudi Arabia about Bleeding with Dental Procedures in Patients Using Antithrombotic Medications

Mohammed Abdullah Alsheef, MD, Sarah Aljohany, PharmD, Jenny Gray, Abdul Rehman Z. Zaidi, MBBS, Ghaydaa Juma Kullab, MD

Blood (2019) 134 (Supplement_1): 5800.

https://doi.org/10.1182/blood-2019-130736

Published: 2019

Journal Articles

Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Maher M Al Johani, MBBS, Raja Chinnappana, PhD, Shimaa Eissaa, PhD, Tarek Owaidah, MDFRCPA, Dana Cialla-Mayc, PhD, Jürgen Poppc, PhD, Mohammed Zourob, PhD

Blood (2018) 132 (Supplement 1): 1247.

https://doi.org/10.1182/blood-2018-99-110689

Published: 2018

Journal Articles

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion

Forat Lutfi, MD, Rohit Boshnoi, MD, Vikas Patel, MD, Aisha Alfasi, Michael Setteducato, Shuyao Zhang, Chintan Shah, MD, Saji Kurian, PharmD, Chethana Kamath, Dae Jun Kim, Martina C. Murphy, MD

Blood (2018) 132 (Supplement 1): 1251.

https://doi.org/10.1182/blood-2018-99-110232

Published: 2018

Journal Articles

Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study

Yan Xu, MD, Tara Gomes, PhD MHSc, Philip S. Wells, MDMSc,FRCP, Ana Johnson, PhD, Michelle Sholzberg, MD

Blood (2018) 132 (Supplement 1): 426.

https://doi.org/10.1182/blood-2018-99-111207

Published: 2018

Journal Articles

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Jan Beyer-Westendorf, MD, Luise Tittl, Christiane Naue, MD, Sandra Marten, MD

Blood (2018) 132 (Supplement 1): 422.

https://doi.org/10.1182/blood-2018-99-118081

Published: 2018

Journal Articles

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Lana A Castellucci, MD, Philip Chiang

Blood (2018) 132 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2018-99-118369

Published: 2018

Journal Articles

Indications, Efficacy and Complications of Kcentra Use in Reversing Coagulopathy

Nithya Sritharan, MD, Darrell Triulzi, MD

Blood (2018) 132 (Supplement 1): 3820.

https://doi.org/10.1182/blood-2018-99-119988

Published: 2018

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

How I treat obese patients with oral anticoagulants

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Risk of Postoperative Bleeding Following Dental Extractions in Patients on Antithrombotic Treatment

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Prothrombin Complex Concentrate in the Management of Major Bleeding Induced By Oral Anticoagulant Therapy: Experience of a Tertiary Care Center

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

Assessment of Utilization of Outpatient Based Treatment for Low Risk Patients with Pulmonary Embolism in Two Community Teaching Hospitals

Heavy Menstrual Bleeding Under-Recognized in Menstruating Women Treated with Oral Anticoagulants

Perception of Dentists and Dental Hygienists in Saudi Arabia about Bleeding with Dental Procedures in Patients Using Antithrombotic Medications

Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion

Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Indications, Efficacy and Complications of Kcentra Use in Reversing Coagulopathy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only